title: Intracranial metastatic prostate carcinoma presenting as intermittent double vision.
abstract: We describe a prostate cancer patient whose initial symptom was intermittent double vision. Intracranial magnetic resonance imaging demonstrated a pituitary mass extending to the cavernous sinus, which caused the double vision. After hormonal therapy for prostate cancer, the pituitary mass disappeared, and double vision was completely resolved without local therapy for the brain. In the 19 months of follow-up after hormone treatment, the prostate cancer remained stable, and the patient remained neurologically intact.
authors.affiliation: Department of Urology, Nippon Medical School, Tokyo, Japan.
authors.forename: Yuka
authors.initials: Y
authors.lastname: Saito
authors.forename: Yukihiro
authors.initials: Y
authors.lastname: Kondo
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Shimizu
authors.forename: Kenta
authors.initials: K
authors.lastname: Kunimoto
authors.forename: Taiji
authors.initials: T
authors.lastname: Nishimura
mesh_terms: D000230:Adenocarcinoma / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D000368:Aged; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D002715:Chlormadinone Acetate / Q000627:therapeutic use; D004172:Diplopia / Q000209:etiology*; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use; D018810:Magnetic Resonance Angiography; D008297:Male; D010911:Pituitary Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary*; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D012074:Remission Induction
chemical_list: D018931:Antineoplastic Agents, Hormonal; D002715:Chlormadinone Acetate; D016729:Leuprolide